Clinuvel Pharmaceuticals
CUV.AX
#7392
Rank
NZ$0.74 B
Marketcap
NZ$14.92
Share price
2.28%
Change (1 day)
10.25%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2024: NZ$58.45 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are NZ$58.85 Million. In 2024 the company made an earning of NZ$58.45 Million, an increase over its 2023 earnings that were of NZ$52.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024NZ$58.45 M11.35%
2023NZ$52.49 M28.31%
2022NZ$40.91 M22.8%
2021NZ$33.31 M112.63%
2020NZ$15.66 M-28.73%
2019NZ$21.98 M32.79%
2018NZ$16.55 M75.41%
2017NZ$9.43 M-332.52%
2016-NZ$4.06 Million-70.68%
2015-NZ$13.85 Million53.78%
2014-NZ$9.01 Million-16.1%
2013-NZ$10.74 Million-37.92%
2012-NZ$17.29 Million-18.19%
2011-NZ$21.14 Million25.31%
2010-NZ$16.87 Million-21.53%
2009-NZ$21.5 Million-11.27%
2008-NZ$24.23 Million80.4%
2007-NZ$13.43 Million-2.46%
2006-NZ$13.77 Million-5.35%
2005-NZ$14.55 Million60.55%
2004-NZ$9.06 Million97.37%
2003-NZ$4.59 Million50.62%
2002-NZ$3.05 Million121.22%
2001-NZ$1.38 Million254.48%
2000-NZ$0.39 Million